|
|
Article: Medtronic Launches New Neuro Oncology Surgical Imaging System Internationally.
- Article from:
- Cancer Weekly
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
This week at the annual Congress of Neurological Surgeons (CNS), Medtronic (NYSE: MDT) announced the Conformite Europeen (CE) mark and international launch of the PoleStar[R] N30 Surgical MRI system, the latest in neuro oncology surgical solutions. The PoleStar N30 System has been submitted to the U.S. Food and Drug Administration for approval (see also Medtronic, Inc.).
Providing real-time imaging in the operating room (OR), the PoleStar Surgical MRI provides surgeons with targeting and navigational accuracy despite the anatomy movement that may occur during a procedure. With intra-operative imaging information, neurosurgeons have more confidence to achieve ...